Brief: Celyad Oncology - As Of March 31, 2021, Co Had Cash And Cash Equivalents Of EUR 12.2 Million ($14.3 Million)

Celyad Oncology SA

06/05/2021 21:27

May 6 (Reuters) - Celyad Oncology SA  CYAD.BR :
    * CELYAD ONCOLOGY - AS OF MARCH 31, 2021, CO HAD CASH AND
CASH
EQUIVALENTS OF EUR 12.2 MILLION ($14.3 MILLION)
    * CELYAD ONCOLOGY - CONFIRMS PREVIOUS GUIDANCE ON CASH BEING
SUFFICIENT TO FUND OPERATING EXPENSES, CAPEX NEEDS UNTIL
MID-2022

Source text for Eikon:  ID:nGNX29NGhZ 
Further company coverage:  CYAD.BR 

 ((Reuters.Briefs@thomsonreuters.com;))